On the other hand, PD-1 and CTLA-4 treatments seem to result in early onset of diabetes in NOD mice, which is in line with the mode of action of these molecules and is also observed in humans clinically (12, 13). The gene discussed is PDCD1; the disease is diabetes mellitus.